TL;DR
MolDeTox introduces a new benchmark for evaluating molecular detoxification using stepwise fragment editing, improving the assessment of toxicity-aware molecular optimization in drug discovery.
Contribution
The paper presents MolDeTox, a novel, detailed benchmark for toxicity-aware molecular optimization that emphasizes fragment-level understanding and evaluation.
Findings
Understanding molecules at the fragment level improves structural validity.
MolDeTox enables more reliable evaluation of toxicity reduction methods.
Analysis reveals strengths and limitations of current models in detoxification tasks.
Abstract
Large Language Models (LLMs) and Vision Language Models (VLMs) have recently shown promising capabilities in various scientific domain. In particular, these advances have opened new opportunities in drug discovery, where the ability to understand and modify molecular structures is critical for optimizing drug properties such as efficacy and toxicity. However, existing models and benchmarks often overlook toxicity-related challenges, focusing primarily on general property optimization without adequately addressing safety concerns. In addition, even existing toxicity repair benchmarks suffer from limited data diversity, low structural validity of generated molecules, and heavy reliance on proxy models for toxicity assessment. To address these limitations, we propose MolDeTox, a novel benchmark for molecular detoxification, designed to enable fine-grained and reliable evaluation of…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
